Activity

Filter

Cancel
Date Panel Item Activity
7 actions
BabyScreen+ newborn screening v0.5 ACTG2 Zornitza Stark Marked gene: ACTG2 as ready
BabyScreen+ newborn screening v0.5 ACTG2 Zornitza Stark Gene: actg2 has been classified as Red List (Low Evidence).
BabyScreen+ newborn screening v0.5 ACTG2 Zornitza Stark Phenotypes for gene: ACTG2 were changed from Megacystis-microcolon-intestinal hypoperistalsis syndrome to Visceral myopathy, MIM#155310; Megacystis-microcolon-intestinal hypoperistalsis syndrome 5, MIM# 619431
BabyScreen+ newborn screening v0.4 ACTG2 Zornitza Stark Classified gene: ACTG2 as Red List (low evidence)
BabyScreen+ newborn screening v0.4 ACTG2 Zornitza Stark Gene: actg2 has been classified as Red List (Low Evidence).
BabyScreen+ newborn screening v0.3 ACTG2 Zornitza Stark reviewed gene: ACTG2: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Visceral myopathy, MIM#155310, Megacystis-microcolon-intestinal hypoperistalsis syndrome 5, MIM# 619431; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
BabyScreen+ newborn screening v0.0 ACTG2 Zornitza Stark gene: ACTG2 was added
gene: ACTG2 was added to gNBS. Sources: BabySeq Category A gene,Expert Review Green
Mode of inheritance for gene: ACTG2 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes for gene: ACTG2 were set to Megacystis-microcolon-intestinal hypoperistalsis syndrome